Approximately 73,000 NEW cases of renal cell carcinoma (RCC) are expected to be diagnosed in 2019 in the United States, with up to 70% of these cases anticipated to be clear-cell subtype.
Ashley K. Losing, PharmD, BCPS, BCOP
Advertisement
Articles by Ashley K. Losing, PharmD, BCPS, BCOP
Advertisement
Latest Updated Articles
Clinical Insights: Use of Combination Therapy for Advanced Clear-Cell Renal Cell CarcinomaPublished: February 29th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
3
CDC Adolescents, Children, & Adult Immunization Schedule: 2025 Update
4
Pharmacists Are Essential Resources in Patient Care Across All Specialties
5
